Translate
Armata Pharmaceuticals, Inc.
About
9.00USD+0.18 +2.04%
Closed • Updated at 10:44 GMT+00:00Market Cap$329.69M
Volume68.7K
Beta0.72
RSI42.97
Gross Margin68.78%
Armata Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02
May 4 2026
Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology"
Apr 27 2026
Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors
Mar 25 2026
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results
Mar 19 2026
Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update
Recent Videos
ARMP STOCK : FRESH BREAKOUT | ARMATA PHARMACEUTICALS STOCK
Apr 23, 2026
This Biotech CEO is Working on Making The Impossible Possible & Helping Us Fight Bad Bacteria.
Apr 07, 2026
ARMP STOCK : FRESH BREAKOUT | ARMATA PHARMACEUTICALS STOCK
Mar 30, 2026
RANGE BREAKOUT | ARMP STOCK ANALYSIS | ARMATA PHARMACEUTICALS STOCK
Feb 28, 2026